RxDoctor Payments Data

Tori Russell, MD

Family Medicine · Columbia, MSNPI 1407980634

Payments from drug & device makers

$4,730in general payments, 2019–2025

Across 284 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$678
  • Lilly USA, LLC$590
  • Astellas Pharma US Inc$472
  • AstraZeneca$428
  • Boehringer Ingelheim$399
  • AbbVie$398
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$4,54096%
  • Education$1904%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,730 in reported general payments places this provider in the 80th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$194,449
Medicare patients
319
Services billed
6,083

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide182$314,843
JardianceEmpagliflozin162$209,453
MounjaroTirzepatide100$162,347
LinzessLinaclotide112$130,179
EliquisApixaban66$64,889
FarxigaDapagliflozin Propanediol53$58,725
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$54,675
MyrbetriqMirabegron35$39,014
XareltoRivaroxaban33$29,547
JanuviaSitagliptin Phosphate23$27,163
ShingrixVaricella-Zoster Ge/As01b/Pf117$26,610
TradjentaLinagliptin21$25,519
VraylarCariprazine Hcl17$23,375
BelsomraSuvorexant31$22,767
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog20$18,997

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$678$314,843182 claims
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat$399$247,604201 claims
Lilly USA, LLCMounjaro$590$162,347100 claims
AbbVieLinzess, Vraylar$398$153,553129 claims
GSKTrelegy Ellipta, Shingrix, Breo Ellipta, Anoro Ellipta$233$102,554217 claims
PfizerEliquis, Nurtec Odt$357$80,47477 claims
AstraZenecaFarxiga, Breztri Aerosphere$428$71,10770 claims
MerckJanuvia, Belsomra, Janumet$229$56,12965 claims
Astellas Pharma US IncMyrbetriq$472$39,01435 claims
Johnson & JohnsonXarelto$396$29,54733 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Columbia

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →